Bradley Merrill Thompson Quoted in “CMS Under Pressure to Cover mHealth Tools for Diabetes Management”

mHealth Intelligence

Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in mHealth Intelligence, in “CMS Under Pressure to Cover mHealth Tools for Diabetes Management,” by Eric Wicklund.

Following is an excerpt:

As federal regulators approve more mHealth devices for diabetes care management and coordination, some in Congress are lobbying for better Medicare coverage of digital health.

A bipartisan group of lawmakers this week asked the Centers for Medicare and Medicaid Services (CMS) to provide coverage for “clinically appropriate treatment” for people living with diabetes, including mobile health devices that measure a user’s blood glucose levels and transmit that data to smartphones and other care management devices – and, eventually, to caregivers. …

The news drew praise from several mHealth advocates. Bradley Merrill Thompson, an attorney with Epstein, Becker and Green who closely follows FDA regulation in digital health, told Politico the FDA “appears to be getting comfortable with what it takes to make an interoperable claim.”